Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print ERCP quality outcomes in a community hospital setting compare favorably with academic centers

ERCP quality outcomes in a community hospital setting compare favorably with academic centers

September 17, 2009

A new study from researchers in Minnesota found that endoscopic retrograde cholangiopancreatography (ERCP) performed in a community hospital setting results in complication rates that compare favorably with those of academic centers while achieving technical success at or above the performance levels recommended by the American Society for Gastrointestinal Endoscopy (ASGE)/American College of Gastroenterology (ACG) Task Force. This is the first large study evaluating complications and quality indicators in a purely non-academic community practice. The study appears in the September issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy.

ERCP is a specialized technique used to study and treat problems of the ducts that drain the liver and pancreas. To reach the ducts, an endoscope is passed through the mouth, past the stomach and into the small intestine (duodenum). A thin tube is then inserted through the endoscope into the common bile duct and pancreatic duct connecting the liver and pancreas to the intestine. A contrast material (dye) is injected through the tube outlining those ducts while X-rays are being taken. The X-rays can show narrowing or blockages in the ducts that may be due to a cancer, gallstones or other abnormalities.




ERCP is technically challenging and is associated with the highest rate of complications among gastroenterological procedures. Because of the attendant risk of ERCP, cases that portend to be more complex are likely to be managed in academic medical centers. Therefore, much of the data regarding complications has been published from academic institutions. Rates of complications have not been well studied in community-based gastroenterology practices.

"This was a prospective study to determine the outcomes and complications of ERCP in a community practice using seven of the eight quality indicators outlined by ASGE, with particular attention to the 30-day complication rate," said study lead author Joshua B. Colton, MD, Minnesota Gastroenterology PA, Maplewood, Minn. "We found that the complication rate was five percent in this community practice, which is very favorable as we know that large ERCP studies from academic centers have documented complication rates of five to 15.9 percent. In addition, our success rates met or exceeded the recommended rates reported by the ASGE/ACG Task Force."

Patients and Methods

The 2006 ASGE/ACG Task Force on Quality in Endoscopy proposed 11 research questions, with five of the questions specifically directed at ERCP in the community setting. In 2002, the ASGE Committee on Outcomes Research published eight ERCP-specific quality indicators designed to provide a more complete description of quality in ERCP. The aim of this prospective study was to determine ERCP quality outcomes, including complications, in a community practice using these quality indicators.

The study was performed from December 1, 2005, through July 31, 2006, at eight community hospitals in Minneapolis, St. Paul and surrounding suburbs in Minnesota. Diagnositic and therapeutic ERCP procedures in both inpatients and outpatients were included. A total of 805 ERCP procedures were performed in 696 patients with a mean age of 61.1 years. Technical success was broken down into three categories: cannulation (insertion of a catheter or wire into the preferred bile or pancreas duct), stone removal and drainage. Each physician completed pre-procedure and post-procedure forms that included patient information, physician intent, findings, grade of difficulty, and technical aspects of the procedure.

Results

ERCP was performed because of known or suspected bile duct stones in over 50 percent of the procedures. A therapeutic intervention (e.g., stone removal, stent placement) was performed in 78 percent of the ERCPs. The overall complication rate following ERCP was five percent, with pancreatitis (post-ERCP pain due to temporary inflammation of the pancreas) being the most common complication at a rate of 3.2 percent. Hemorrhage (bleeding) occurred in less than one percent of procedures.

The ASGE/ACG Task Force has recommended competence levels for cannulation of the bile duct (90 percent), bile duct stone removal (85 percent), and bile duct drainage of a blocked duct (90 percent). This group of gastroenterologists performing ERCP in a community, non-academic setting met or exceeded these levels of success. Cannulation was successful in 94 percent, stone removal in 87 percent and drainage in 90 percent of the cases.

Researchers noted that these results may not be applicable to all community practices. The study center, Minnesota Gastroenterology PA, is a very large private practice composed of approximately 50 gastroenterologists allowing for a degree of specialization within the practice. The select group of physicians performing ERCP had a mean of 16.6 years of ERCP experience. Although this study did not find any relationship between years of experience and complication rates, several previous studies demonstrated a relationship. Further, the observation in previous studies that more complex cases tend to be handled at academic centers while "routine" cases are managed at community centers diminishes the ability to compare outcomes and complication rates between the two venues.

The study authors conclude that their results address issues that have not previously been well-studied and, when taken together with data from academic departments, provide a more complete picture of ERCP quality indices.

American Society for Gastrointestinal Endoscopy



Related Bile Duct Current Events and Bile Duct News Articles Bile Duct Current Events and Bile Duct News RSS Bile Duct Current Events and Bile Duct News RSS
What relates to the short-term effectiveness of biliary drainage?
Biliary drainage is performed as a palliative treatment of hilar cholangiocarcinoma. The reduction of serum bilirubin is usually the hallmark of successful biliary drainage. However, some patients may have persistent jaundice or scanty bile output after biliary drainage.

Parasite growth hormone pushes human cells to liver cancer
Scientists have found that the human liver fluke (Opisthorchis viverrini) contributes to the development of bile duct (liver) cancer by secreting granulin, a growth hormone that is known to cause uncontrolled growth of cells.

Is endotoxin receptor CD14 rs2569190/C-159T gene correlated with chronic hepatitis C?
It is still unknown why the natural history of chronic disease caused by hepatitis C virus (HCV), which currently infects 3% of the world's population, varies from mild in some patients to rapidly progressing in others.

Hepatic injury in cholelithiasis and cholecystitis
Acute hepatocellular injury is a commonly encountered phenomenon in patients with cholelithiasis and concomitant common bile duct (CBD) stones.

Perform non-radiation ERCP during pregnancy: Is it safe?
Hormonal changes during pregnancy increase the lithogenicity of bile and impair gallbladder emptying, which create a favorable environment for gallstone formation.

Gallbladder emptying in primary sclerosing cholangitis patients
Primary sclerosing cholangitis (PSC) is an idiopathic chronic cholestatic inflammatory liver disease characterized by diffuse fibrosing inflammation of intra- and/or extrahepatic bile ducts, resulting in bile duct obliteration, biliary cirrhosis, and eventually hepatic failure.

Scientists link immune system's natural killer cells to infant liver disease
Scientists have linked an overactive response by one of the immune system's key weapons against infection - natural killer, or NK, cells - to the onset of biliary atresia in infants, a disease where blocked bile ducts can cause severe liver damage and death.

Serum bile acid profiling for inflammatory bowel disease characterization
Based on serum bank material, BA profiling was applied in IBD patients and healthy controls which showed that most but not all BA species were decreased to a different extent in CD and UC.

Improved DNA stool test could detect digestive cancers in multiple organs
Mayo Clinic researchers have demonstrated that a noninvasive screening test can detect not only colorectal cancer but also the common cancers above the colon -- including pancreas, stomach, biliary and esophageal cancers.

Mayo Clinic finds new pathology tests double sensitivity to detect bile duct and pancreatic cancers
Pancreatic cancer and bile duct cancer are difficult to diagnose and often fatal because they are discovered in the advanced stages of the disease.
More Bile Duct Current Events and Bile Duct News Articles
21st Century Complete Medical Guide to Cancer of the Small Intestine, Gallbladder, and Bile Duct - Authoritative Government Documents and Clinical References ... on Diagnosis and Treatment Options

21st Century Complete Medical Guide to Cancer of the Small Intestine, Gallbladder, and Bile Duct - Authoritative Government Documents and Clinical References ... on Diagnosis and Treatment Options
by PM Medical Health News (Author)

This up-to-date and comprehensive CD-ROM provides a superb collection of official Federal government documents on cancer of the small intestine, gallbladder, and bile duct: signs and symptoms, diagnosis, lab tests, treatment and management options, and ongoing clinical research. Every aspect of the disease is thoroughly covered. There is no other reference that is as fast, convenient, and portable - everything you need to know, from the federal sources you trust. Cancers covered include those of the small intestine, gallbladder, and extrahepatic bile duct.

For patients, practical information is provided in clearly written patient education documents. For medical professionals, doctor references and texts have detailed technical information and clinical background material. Documents...

Beating Bile Duct Cancer Together Sweatshirt XXX-Large White

Beating Bile Duct Cancer Together Sweatshirt XXX-Large White
by Shop Zeus



Beating Bile Duct Cancer Together Mug

Beating Bile Duct Cancer Together Mug
by Design a Product LLC

Text on mug: Beating Bile Duct Cancer Together
* Custom coffee mugs are dishwasher-safe and microwave-safe. Colors are permanently baked into the mug''s surface.
* If you have new ideas or need help selecting text for your custom coffee mugs please contact us.
* Size: 11 oz. capacity ceramic coffee mug.

I Am Jack's Raging Bile Duct

I Am Jack's Raging Bile Duct
Snapback (Primary Contributor)



American Hepato-Pancreato-Biliary Association 2005 Meeting -DVD 3

American Hepato-Pancreato-Biliary Association 2005 Meeting -DVD 3
Also With: American Hepato-Pancreato-Biliary Association (Host)

2005 A.H.P.B.A. Meeting April 14-17,2005 Florida, USA Laparoscopic Pancreas and bile duct Symposium -Laparoscopic pancreatic debridement Dr. Karen D. Horvath (USA) -Bile duct stricture management Dr. David L. Carr-Locke (USA) -Laparoscopic common duct exploration Dr. Stanley James Rogers (USA)

  Radiology of the Gallbladder and Bile Ducts (Golden's diagnostic radiology ; section 22)
by Philip M. Hatfield (Author)



CHOLYSTIN (JIN DAN PIAN) 500mg X 100 tablets per box

CHOLYSTIN (JIN DAN PIAN) 500mg X 100 tablets per box
by Shanghai Shangyao

CHOLYSTIN (JIN DAN PIAN) Functions and indications:,br> Regulates the acute and chronic disorder of gallbladder. Use for the discomfort caused by bile duct infection. Caution: Do not use if pregnant Ingredients: Lysimachiae leaf, Gentianae root, Polycuspidati root Contents: 100 tablets (500mg each) Directions: Take 5 tablets 2 times a day as a herbal supplement. This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

  Video Perspectives in Surgical Laparoscopy: Commom Bile Duct Petelin [VHS]



Diseases of the liver and bile ducts

Diseases of the liver and bile ducts
by George Y. Wu (Editor)

Univ. of Connecticut, Farmington, CT. Practice manual providing the clinician with an understanding of the utility and limitations of the ways in which the liver is evaluated. Includes outlines and algorithms. Halftone illustrations. DNLM: Liver Diseases--diagnosis.

Fight Against Extrahepatic Bile Duct Cancer Long Sleeve T-shirt Large White

Fight Against Extrahepatic Bile Duct Cancer Long Sleeve T-shirt Large White
by Shop Zeus



© 2009 BrightSurf.com